Lunesta and Acetaminophen Interaction: What You Need to Know
Can you take Lunesta (eszopiclone) with acetaminophen (Tylenol)? A physician-reviewed guide covering the mechanism, risk level, monitoring, and safe dosing for this drug combination.
Eszopiclone: Drug Interactions
30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
30articles
3topic areas covered
Jan 28, 2025latest review
Eszopiclone: Drug Interactions library
Showing 30 of 30 clinical reviews.
Lunesta and Apixaban Interaction: Safety, Risks, and Clinical Guidance
Can you take Lunesta (eszopiclone) with apixaban (Eliquis)? A physician-reviewed guide covering CYP3A4 overlap, bleeding risk, dose adjustments, and monitoring recommendations.
Lunesta and Atorvastatin Interaction: CYP3A4 Overlap, Risks, and Monitoring
Can you take Lunesta (eszopiclone) with atorvastatin? A pharmacist-level review of the CYP3A4 interaction, clinical severity, dose adjustments, and safety monitoring.
Lunesta and Benzodiazepines Interaction: Risks, Mechanism, and Clinical Guidance
Eszopiclone (Lunesta) combined with benzodiazepines carries serious CNS depression risks. Learn the pharmacologic mechanism, severity rating, dose adjustments, and monitoring protocols from primary sources.
Lunesta and Bupropion Interaction: Safety, Risks, and Clinical Guidance
Can you take Lunesta (eszopiclone) with bupropion? A physician-reviewed guide covering the CYP metabolism, pharmacodynamic risks, monitoring parameters, and dose-adjustment considerations for this combination.
Lunesta and Clopidogrel Interaction: What Prescribers and Patients Should Know
Clinical guide to the eszopiclone (Lunesta) and clopidogrel drug interaction, covering CYP enzyme competition, severity rating, monitoring requirements, dose adjustments, and patient counseling.
Lunesta and Diphenhydramine Interaction: What You Need to Know
A clinician-level review of the eszopiclone, diphenhydramine drug interaction, covering mechanism, severity, dose guidance, monitoring, and patient counseling backed by primary literature.
Lunesta and Estradiol HRT Interaction: Safety, CYP3A4 Metabolism, and Dose Guidance
Clinical guide to the eszopiclone (Lunesta) and estradiol HRT drug interaction, covering CYP3A4 metabolism, severity ratings, dose adjustments, and monitoring protocols.
Lunesta and Finasteride Interaction: What Patients and Clinicians Need to Know
A clinical deep-dive into the eszopiclone (Lunesta) and finasteride drug interaction: CYP3A4 overlap, CNS sedation risk, pharmacokinetic mechanisms, monitoring protocols, and dose-adjustment guidance backed by primary literature.
Lunesta and Gabapentin Interaction: Safety, Risks, and Clinical Guidance
Board-reviewed guide to the eszopiclone (Lunesta) and gabapentin drug interaction, covering mechanism, severity, dose adjustments, monitoring, and patient counseling.
Lunesta and Hormonal Contraceptives: Drug Interaction Guide
Clinical review of the eszopiclone (Lunesta) and hormonal contraceptives interaction, covering CYP3A4 metabolism, efficacy concerns, dose adjustments, and safety monitoring.
Lunesta and Levothyroxine Interaction: What Patients and Clinicians Need to Know
A clinical deep-dive into the eszopiclone, levothyroxine drug interaction: mechanism, severity, absorption timing, CYP3A4 involvement, monitoring, and patient counseling backed by primary literature.
Lunesta and Metformin Interaction: What Patients and Prescribers Need to Know
A clinician-reviewed deep dive into the eszopiclone-metformin drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling points.
Lunesta and NSAIDs (Ibuprofen, Naproxen): Drug Interaction Guide
Can you take Lunesta (eszopiclone) with NSAIDs like ibuprofen or naproxen? Review the pharmacokinetic and pharmacodynamic interaction profile, safety data, monitoring recommendations, and dose-adjustment guidance.
Lunesta and Opioids (Oxycodone, Hydrocodone, Tramadol) Interaction
Clinical guide to the eszopiclone-opioid interaction: mechanism, severity, dose adjustments, monitoring parameters, and safer alternatives for patients requiring both sleep and pain management.
Lunesta and PPIs (Omeprazole, Pantoprazole) Interaction
Clinical guide to the eszopiclone-PPI interaction: CYP3A4 mechanism, severity grading, dose-adjustment considerations, monitoring, and patient counseling for combining Lunesta with omeprazole or pantoprazole.
Lunesta and Prednisone Interaction: Safety, Risks, and Clinical Guidance
Can you take Lunesta (eszopiclone) with prednisone? A physician-reviewed guide covering CYP3A4 metabolism overlap, CNS depression risk, glucose monitoring, and dose-adjustment strategies.
Lunesta and Pregabalin Interaction: Safety, Risks, and Clinical Guidance
Can you take Lunesta (eszopiclone) with pregabalin? Learn about the pharmacodynamic interaction, CNS depression risk, dose adjustments, and monitoring protocols backed by FDA labeling and clinical evidence.
Lunesta and Progesterone HRT Interaction: Safety, Risks, and Clinical Guidance
Can you take Lunesta (eszopiclone) with progesterone HRT? A physician-reviewed guide covering CYP3A4 overlap, additive GABA-A sedation, dose adjustments, and monitoring protocols.
Lunesta and Rivaroxaban Interaction: What Patients and Clinicians Need to Know
A clinician-reviewed guide to the eszopiclone, rivaroxaban drug interaction: CYP3A4 mechanism, bleeding and CNS sedation risks, monitoring parameters, dose considerations, and safer alternatives.
Lunesta and Rosuvastatin Interaction: What Patients and Clinicians Need to Know
A clinical deep-dive into the eszopiclone, rosuvastatin drug interaction: mechanism, severity, monitoring parameters, dose guidance, and patient counseling from the HealthRX medical team.
Lunesta and Sildenafil Interaction: What You Need to Know
A physician-reviewed guide to the eszopiclone, sildenafil drug interaction: mechanism, risk level, monitoring, dose adjustments, and patient counseling based on FDA labeling and primary pharmacology literature.
Lunesta and Simvastatin Interaction: CYP3A4 Risk, Monitoring, and Dose Guidance
Eszopiclone (Lunesta) and simvastatin share CYP3A4 metabolism. Learn the clinical significance of this interaction, dose adjustments, monitoring parameters, and safe co-prescribing strategies.
Lunesta and SNRIs (Venlafaxine, Duloxetine) Interaction: Safety, Risks, and Clinical Guidance
Can you take Lunesta (eszopiclone) with SNRIs like venlafaxine or duloxetine? A physician-reviewed guide covering mechanisms, severity, dose adjustments, and monitoring.
Lunesta and SSRIs (Sertraline, Escitalopram) Interaction: What You Need to Know
A physician-reviewed guide to the eszopiclone, SSRI interaction, covering mechanism, severity, monitoring parameters, dose adjustments, and patient counseling for sertraline and escitalopram combinations.
Lunesta and Tadalafil Interaction: What Patients and Clinicians Need to Know
A physician-reviewed guide to the eszopiclone, tadalafil drug interaction, covering mechanism, severity, monitoring, dose adjustment, and patient counseling backed by primary literature.
Lunesta and Testosterone Interaction: Safety, CYP Overlap, and Monitoring
Can you take Lunesta (eszopiclone) with testosterone? A clinical review of the pharmacokinetic and pharmacodynamic interaction, CYP3A4 metabolism, risk factors, and monitoring protocols.
Lunesta and Trazodone Interaction: What Patients and Clinicians Need to Know
A clinician-reviewed guide to the eszopiclone-trazodone drug interaction: mechanism, severity, dose guidance, monitoring, and patient counseling based on FDA labeling and primary literature.
Lunesta and Warfarin Interaction: What Clinicians and Patients Should Know
Eszopiclone (Lunesta) and warfarin have minimal pharmacokinetic interaction per FDA data, but warfarin's narrow therapeutic index and shared CYP3A4 metabolism still warrant INR monitoring. Full clinical review with citations.
Lunesta and Zolpidem Interaction: What Clinicians and Patients Need to Know
Combining eszopiclone (Lunesta) and zolpidem carries serious CNS depression risk. Learn the mechanism, severity rating, monitoring parameters, dose adjustments, and patient counseling points backed by FDA labels and primary literature.